TIC10

• Description:

  TIC10 inactivates Akt and ERK to induce TRAIL through Foxo3a, possesses superior drug properties: delivery across the blood-brain barrier, superior stability and improved pharmacokinetics. Phase 1/2.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  386.49

• Molecular Formula:

  C24H26N4O

• Notes:

  Research use only, not for human use.

• Receptor:

  TRAIL

• CAS Number:

  1616632-77-9